Position in ABBV
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$723,914,175
+$124,456,059 QoQ
Shares Held
2,876,785
+4.4% QoQ
Ownership
0.163%
of shares outstanding
% of Portfolio
1.70%
of 13F equity value
Holder Rank
#64
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fayez Sarofim & Co holds $1,793,961,393 across 10 Drug Manufacturers - General names. ABBV ranks #1 (40.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
2,876,785 | $723,914,175 | |
| 2 | LLY |
ELI LILLY & Co
|
425,688 | $510,582,998 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,664,909 | $213,940,806 | |
| 4 | JNJ |
Johnson & Johnson
|
688,542 | $174,869,011 | |
| 5 | NVO |
Novo Nordisk A S
|
2,924,500 | $140,200,529 | |
| 6 | AMGN |
Amgen Inc
|
54,394 | $19,697,155 | |
| 7 | PFE |
Pfizer Inc
|
233,339 | $5,618,802 | |
| 8 | NVS |
Novartis AG
|
28,162 | $4,413,548 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $723,914,175 | 2,876,785 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $599,458,116 | 2,756,256 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $590,465,684 | 2,584,208 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $500,891,638 | 2,163,305 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $402,423,231 | 2,167,995 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $453,876,680 | 2,166,269 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $392,039,606 | 2,206,188 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $405,405,506 | 2,052,894 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $347,985,435 | 2,028,833 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $350,565,079 | 1,925,124 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $299,595,132 | 1,933,246 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $297,889,701 | 1,998,455 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $257,457,711 | 1,910,916 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $330,549,794 | 2,074,103 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $326,565,809 | 2,020,703 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $295,565,313 | 2,202,260 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $338,020,290 | 2,206,975 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $359,227,328 | 2,215,948 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $298,940,858 | 2,207,835 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $236,684,145 | 2,194,161 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $271,390,759 | 2,409,364 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $318,278,048 | 2,941,028 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $327,878,676 | 3,059,997 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $278,624,050 | 3,181,003 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $336,879,730 | 3,431,246 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $232,102,776 | 3,046,368 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||